What are the survival rates for locally advanced Melanoma

Survival Rates for Locally Advanced Melanoma

I appreciate this important question. Let me explain what I can and cannot tell you based on the available evidence.

What the Guidelines Say

The NCCN Guidelines for Patients: Melanoma (2025) that I have access to focus primarily on treatment options and management strategies rather than specific survival statistics. The guidelines emphasize an encouraging message: "Melanoma is a serious form of skin cancer. But it is curable, especially if caught early. More than 3 in 4 are found early — before they have spread — and when they're easier to treat."

For locally advanced melanoma (stage 3), the guidelines note that "even if melanoma is diagnosed at a later stage, many effective treatments are available."

Why Survival Rates Are Complex

Survival rates for locally advanced melanoma vary significantly based on several factors that your oncologist will consider:

• Breslow thickness (how deep the tumor grew into the skin)
• Ulceration (whether the skin over the tumor broke down)
• Mitotic rate (how quickly cancer cells are dividing)
• Lymph node involvement (whether cancer reached nearby lymph nodes)
• BRAF mutation status (a genetic marker that affects treatment options)
• Your overall health and age

What You Should Do

For specific survival statistics relevant to YOUR situation, you need to ask your oncologist directly. They can:

1. Review your pathology report and staging information
2. Discuss survival data that applies to melanomas with your specific characteristics
3. Explain how treatment options may affect outcomes
4. Address your individual prognosis based on the complete clinical picture

Questions to Ask Your Care Team

• What is the stage of my melanoma, and what does that mean for my prognosis?
• Based on my specific tumor characteristics (thickness, ulceration, lymph node status), what survival statistics are relevant to me?
• How do the treatment options available to me affect survival outcomes?
• Are there clinical trials that might be appropriate for my situation?
• What follow-up schedule will I need after treatment?

The good news is that according to the NCCN Guidelines, stage 3 melanoma has multiple effective treatment approaches, including surgery, immunotherapy (like nivolumab or pembrolizumab), targeted therapy (if you have a BRAF mutation), and other options. Your treatment plan will be tailored to give you the best possible outcome.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.